Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
73.83
-0.15 (-0.20%)
Jun 20, 2025, 4:00 PM - Market closed
Edwards Lifesciences Stock Forecast
Stock Price Forecast
The 20 analysts that cover Edwards Lifesciences stock have a consensus rating of "Buy" and an average price target of $80.2, which forecasts a 8.63% increase in the stock price over the next year. The lowest target is $60 and the highest is $95.
Price Target: $80.2 (+8.63%)
Analyst Consensus: Buy
* Price targets were last updated on May 22, 2025.
Analyst Ratings
The average analyst rating for Edwards Lifesciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Hold | 10 | 10 | 10 | 9 | 9 | 9 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 21 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $84 → $95 | Strong Buy | Maintains | $84 → $95 | +28.67% | May 22, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $80 → $83 | Buy | Maintains | $80 → $83 | +12.42% | May 13, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $71 → $75 | Hold | Maintains | $71 → $75 | +1.58% | Apr 25, 2025 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $73 → $80 | Hold → Buy | Upgrades | $73 → $80 | +8.36% | Apr 24, 2025 |
| Baird | Baird | Hold Maintains $72 → $75 | Hold | Maintains | $72 → $75 | +1.58% | Apr 24, 2025 |
Financial Forecast
Revenue This Year
6.08B
from 5.44B
Increased by 11.81%
Revenue Next Year
6.66B
from 6.08B
Increased by 9.54%
EPS This Year
2.55
from 6.97
Decreased by -63.36%
EPS Next Year
2.85
from 2.55
Increased by 11.58%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.3B | 7.0B | 7.8B | ||
| Avg | 6.1B | 6.7B | 7.4B | ||
| Low | 5.7B | 6.1B | 6.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.4% | 15.3% | 17.4% | ||
| Avg | 11.8% | 9.5% | 10.4% | ||
| Low | 4.0% | 0.5% | -2.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.93 | 3.22 | 3.45 | ||
| Avg | 2.55 | 2.85 | 3.18 | ||
| Low | 2.37 | 2.56 | 2.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -58.0% | 26.3% | 21.3% | ||
| Avg | -63.4% | 11.6% | 11.8% | ||
| Low | -66.0% | 0.2% | -5.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.